Pacira BioSciences, Inc. PCRX Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s operating lease liabilities?
- Pacira BioSciences, Inc. (PCRX) reported operating lease liabilities of $33.71M in Q1 2026.
- How has Pacira BioSciences, Inc.'s operating lease liabilities changed year-over-year?
- Pacira BioSciences, Inc.'s operating lease liabilities decreased by 22.8% year-over-year, from $43.68M to $33.71M.
- What is the long-term trend for Pacira BioSciences, Inc.'s operating lease liabilities?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s operating lease liabilities has grown at a -12.6% compound annual growth rate (CAGR), from $71.03M to $36.18M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.